Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rafi

Showing results (41-50 of 106) with videos related to

Pageof 11
Sort By:
American Journal of Human Genetics|June 1, 1992
Correction of sulfatide metabolism after transfer of prosaposin cDNA to cultured cells from a patient with SAP-1 deficiencyM A Rafi, S Amini, X L Zhang, et al.
Journal of Drug Targeting|March 3, 2020
Bioengineered smart bacterial carriers for combinational targeted therapy of solid tumoursSiamak Alizadeh, Abolghasem Esmaeili, Abolfazl Barzegari, et al.
Biochemical and Biophysical Research Communications|January 30, 1990
Detection of a point mutation in sphingolipid activator protein-1 mRNA in patients with a variant form of metachromatic leukodystrophyM A Rafi, X L Zhang, G DeGala, et al.
Expert Opinion on Drug Safety|June 9, 2016
Detection of cases of progressive multifocal leukoencephalopathy associated with new biologicals and targeted cancer therapies from the FDA's adverse event reporting systemDennis W Raisch, John A Rafi, Cheng Chen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 3, 2015
Long-term Improvements in Lifespan and Pathology in CNS and PNS After BMT Plus One Intravenous Injection of AAVrh10-GALC in Twitcher MiceMohammad A Rafi, Han Zhi Rao, Paola Luzi, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1990
Insertion in the mRNA of a metachromatic leukodystrophy patient with sphingolipid activator protein-1 deficiencyX L Zhang, M A Rafi, G DeGala, et al.
Human Genetics|June 1, 1991
The mechanism for a 33-nucleotide insertion in mRNA causing sphingolipid activator protein (SAP-1)-deficient metachromatic leukodystrophyX L Zhang, M A Rafi, G DeGala, et al.
Gene|September 5, 2013
Sixteen novel mutations in the arylsulfatase A gene causing metachromatic leukodystrophyPaola Luzi, Mohammad A Rafi, Han Zhi Rao, et al.
Human Molecular Genetics|November 1, 1993
Cloning and expression of cDNA encoding human galactocerebrosidase, the enzyme deficient in globoid cell leukodystrophyY Q Chen, M A Rafi, G de Gala, et al.
Blood|December 3, 1998
Role of spontaneous and interleukin-2-induced natural killer cell activity in the cytotoxicity and rejection of Fas+ and Fas- tumor cellsM Bradley, A Zeytun, A Rafi-Janajreh, et al.
Pageof 11

Showing results (41-50 of 106) with videos related to

Sort By:
Pageof 11
American Journal of Human Genetics|June 1, 1992
Correction of sulfatide metabolism after transfer of prosaposin cDNA to cultured cells from a patient with SAP-1 deficiencyM A Rafi, S Amini, X L Zhang, et al.
Journal of Drug Targeting|March 3, 2020
Bioengineered smart bacterial carriers for combinational targeted therapy of solid tumoursSiamak Alizadeh, Abolghasem Esmaeili, Abolfazl Barzegari, et al.
Biochemical and Biophysical Research Communications|January 30, 1990
Detection of a point mutation in sphingolipid activator protein-1 mRNA in patients with a variant form of metachromatic leukodystrophyM A Rafi, X L Zhang, G DeGala, et al.
Expert Opinion on Drug Safety|June 9, 2016
Detection of cases of progressive multifocal leukoencephalopathy associated with new biologicals and targeted cancer therapies from the FDA's adverse event reporting systemDennis W Raisch, John A Rafi, Cheng Chen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 3, 2015
Long-term Improvements in Lifespan and Pathology in CNS and PNS After BMT Plus One Intravenous Injection of AAVrh10-GALC in Twitcher MiceMohammad A Rafi, Han Zhi Rao, Paola Luzi, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1990
Insertion in the mRNA of a metachromatic leukodystrophy patient with sphingolipid activator protein-1 deficiencyX L Zhang, M A Rafi, G DeGala, et al.
Human Genetics|June 1, 1991
The mechanism for a 33-nucleotide insertion in mRNA causing sphingolipid activator protein (SAP-1)-deficient metachromatic leukodystrophyX L Zhang, M A Rafi, G DeGala, et al.
Gene|September 5, 2013
Sixteen novel mutations in the arylsulfatase A gene causing metachromatic leukodystrophyPaola Luzi, Mohammad A Rafi, Han Zhi Rao, et al.
Human Molecular Genetics|November 1, 1993
Cloning and expression of cDNA encoding human galactocerebrosidase, the enzyme deficient in globoid cell leukodystrophyY Q Chen, M A Rafi, G de Gala, et al.
Blood|December 3, 1998
Role of spontaneous and interleukin-2-induced natural killer cell activity in the cytotoxicity and rejection of Fas+ and Fas- tumor cellsM Bradley, A Zeytun, A Rafi-Janajreh, et al.
Pageof 11